| Dr Cathleen J Mullarkey-desapio, MD | |
|
419 N Harrison St, Princeton, NJ 08540-3594 | |
| (609) 924-9300 | |
| (609) 430-9481 |
| Full Name | Dr Cathleen J Mullarkey-desapio |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 40 Years |
| Location | 419 N Harrison St, Princeton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225073505 | NPI | - | NPPES |
| 0479900 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 25MA05531300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Peter's University Hospital | New brunswick, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Peters University Hospital | 9931012382 | 110 |
News Archive
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.
The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.
A review of 21 studies that analyzed the effectiveness of modifying nutritional intake as a treatment for improving sleep found mixed results, as reported in the article "Systematic Review of Dietary Interventions Targeting Sleep Behavior (http://online.liebertpub.com/doi/full/10.1089/acm.2015.0238)" in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on The Journal of Alternative and Complementary Medicine (http://online.liebertpub.com/doi/full/10.1089/acm.2015.0238) website until May 21, 2016.
Soldiers injured during the conflicts in Iraq and Afghanistan have the highest survival rates in history, thanks to the availability of surgeons skilled in combat care. But combat-ready surgical skills are hard to sustain off the battlefield.
In their American Society of Reproductive Medicine (ASRM) conference wrap-up, Medscape highlighted the article published by them on October 27, 2009, which summarized the results from the largest prospective, randomized clinical study to compare vaginal progesterone to intramuscular progesterone injections (IM progesterone) for luteal support in infertility treatment.
› Verified 8 days ago
| Entity Name | Saint Peters University Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114924834 PECOS PAC ID: 9931012382 Enrollment ID: O20040112000043 |
News Archive
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.
The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.
A review of 21 studies that analyzed the effectiveness of modifying nutritional intake as a treatment for improving sleep found mixed results, as reported in the article "Systematic Review of Dietary Interventions Targeting Sleep Behavior (http://online.liebertpub.com/doi/full/10.1089/acm.2015.0238)" in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on The Journal of Alternative and Complementary Medicine (http://online.liebertpub.com/doi/full/10.1089/acm.2015.0238) website until May 21, 2016.
Soldiers injured during the conflicts in Iraq and Afghanistan have the highest survival rates in history, thanks to the availability of surgeons skilled in combat care. But combat-ready surgical skills are hard to sustain off the battlefield.
In their American Society of Reproductive Medicine (ASRM) conference wrap-up, Medscape highlighted the article published by them on October 27, 2009, which summarized the results from the largest prospective, randomized clinical study to compare vaginal progesterone to intramuscular progesterone injections (IM progesterone) for luteal support in infertility treatment.
› Verified 8 days ago
| Entity Name | Princeton Endocrinology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356587505 PECOS PAC ID: 4688730922 Enrollment ID: O20090311000497 |
News Archive
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.
The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.
A review of 21 studies that analyzed the effectiveness of modifying nutritional intake as a treatment for improving sleep found mixed results, as reported in the article "Systematic Review of Dietary Interventions Targeting Sleep Behavior (http://online.liebertpub.com/doi/full/10.1089/acm.2015.0238)" in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on The Journal of Alternative and Complementary Medicine (http://online.liebertpub.com/doi/full/10.1089/acm.2015.0238) website until May 21, 2016.
Soldiers injured during the conflicts in Iraq and Afghanistan have the highest survival rates in history, thanks to the availability of surgeons skilled in combat care. But combat-ready surgical skills are hard to sustain off the battlefield.
In their American Society of Reproductive Medicine (ASRM) conference wrap-up, Medscape highlighted the article published by them on October 27, 2009, which summarized the results from the largest prospective, randomized clinical study to compare vaginal progesterone to intramuscular progesterone injections (IM progesterone) for luteal support in infertility treatment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cathleen J Mullarkey-desapio, MD 419 N Harrison St, Princeton, NJ 08540-3594 Ph: (609) 924-9300 | Dr Cathleen J Mullarkey-desapio, MD 419 N Harrison St, Princeton, NJ 08540-3594 Ph: (609) 924-9300 |
News Archive
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.
The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.
A review of 21 studies that analyzed the effectiveness of modifying nutritional intake as a treatment for improving sleep found mixed results, as reported in the article "Systematic Review of Dietary Interventions Targeting Sleep Behavior (http://online.liebertpub.com/doi/full/10.1089/acm.2015.0238)" in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on The Journal of Alternative and Complementary Medicine (http://online.liebertpub.com/doi/full/10.1089/acm.2015.0238) website until May 21, 2016.
Soldiers injured during the conflicts in Iraq and Afghanistan have the highest survival rates in history, thanks to the availability of surgeons skilled in combat care. But combat-ready surgical skills are hard to sustain off the battlefield.
In their American Society of Reproductive Medicine (ASRM) conference wrap-up, Medscape highlighted the article published by them on October 27, 2009, which summarized the results from the largest prospective, randomized clinical study to compare vaginal progesterone to intramuscular progesterone injections (IM progesterone) for luteal support in infertility treatment.
› Verified 8 days ago
Dr. Subhashis Banerjee, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3551 Lawrenceville Rd, Princeton, NJ 08540 Phone: 609-252-7269 | |
Dr. Shirley Bembo, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 601 Ewing St, C-8, Princeton, NJ 08540 Phone: 609-924-4433 Fax: 609-924-4423 | |
Mrs. Ewa Ruel, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 601 Ewing St Ste C8, Princeton, NJ 08540 Phone: 609-924-4433 Fax: 609-924-4423 | |
Dr. Benny Soffer, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 15 Bainbridge St, Princeton, NJ 08540 Phone: 609-751-0370 | |
Danielle Coppola, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2 Cleveland Ln, Princeton, NJ 08540 Phone: 609-876-0067 | |
Dr. Laura Hildebrant, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 727 State Rd, Suite 1, Princeton, NJ 08540 Phone: 609-921-6410 Fax: 609-921-0406 | |
Dr. Andrew Costin, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 419 N Harrison St, Princeton, NJ 08540 Phone: 609-924-9300 Fax: 609-430-9481 |